Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

HHV-8-related hemophagocytic lymphohistiocytosis in a boy with XLP phenotype.

Pasic S, Cupic M, Lazarevic I.

J Pediatr Hematol Oncol. 2012 Aug;34(6):467-71. doi: 10.1097/MPH.0b013e3182375372.

PMID:
22258354
2.

Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2.

Yang X, Wada T, Imadome K, Nishida N, Mukai T, Fujiwara M, Kawashima H, Kato F, Fujiwara S, Yachie A, Zhao X, Miyawaki T, Kanegane H.

Herpesviridae. 2012 Feb 10;3(1):1. doi: 10.1186/2042-4280-3-1.

3.

X-linked lymphoproliferative disease in an adult.

Hoshino T, Kanegane H, Doki N, Irisawa H, Sakura T, Nojima Y, Miyawaki S, Miyawaki T.

Int J Hematol. 2005 Jul;82(1):55-8.

PMID:
16105760
4.

Fatal hemophagocytic syndrome related to active human herpesvirus-8/Kaposi sarcoma-associated herpesvirus infection in human immunodeficiency virus-negative, non-transplant patients without related malignancies.

Re A, Facchetti F, Borlenghi E, Cattaneo C, Capucci MA, Ungari M, Barozzi P, Vallerini D, Potenza L, Torelli G, Rossi G, Luppi M.

Eur J Haematol. 2007 Apr;78(4):361-4. Epub 2007 Jan 22.

PMID:
17331129
6.

Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).

Pachlopnik Schmid J, Canioni D, Moshous D, Touzot F, Mahlaoui N, Hauck F, Kanegane H, Lopez-Granados E, Mejstrikova E, Pellier I, Galicier L, Galambrun C, Barlogis V, Bordigoni P, Fourmaintraux A, Hamidou M, Dabadie A, Le Deist F, Haerynck F, Ouachée-Chardin M, Rohrlich P, Stephan JL, Lenoir C, Rigaud S, Lambert N, Milili M, Schiff C, Chapel H, Picard C, de Saint Basile G, Blanche S, Fischer A, Latour S.

Blood. 2011 Feb 3;117(5):1522-9. doi: 10.1182/blood-2010-07-298372. Epub 2010 Nov 30.

7.

Hemophagocytic lymphohistiocytosis in a patient with x-linked lymphoproliferative disease.

Bird JA, McClain KL, Rosenblatt HM, Abramson SL, Hanson IC.

Allergy Asthma Proc. 2009 Jul-Aug;30(4):458-62. doi: 10.2500/aap.2009.30.3259.

PMID:
19772767
8.

Primary Immunodeficiencies Inducing EBV-Associated Severe Illnesses.

Miyawaki T.

Iran J Allergy Asthma Immunol. 2004 Jun;3(2):51-7.

9.

Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency.

Wada T, Kanegane H, Ohta K, Katoh F, Imamura T, Nakazawa Y, Miyashita R, Hara J, Hamamoto K, Yang X, Filipovich AH, Marsh RA, Yachie A.

Cytokine. 2014 Jan;65(1):74-8. doi: 10.1016/j.cyto.2013.09.007. Epub 2013 Sep 29.

PMID:
24084330
10.

X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis.

Kanegane H, Ito Y, Ohshima K, Shichijo T, Tomimasu K, Nomura K, Futatani T, Sumazaki R, Miyawaki T.

Am J Hematol. 2005 Feb;78(2):130-3.

11.

Lymphoproliferative Disease, X-Linked.

Filipovich A, Johnson J, Zhang K, Marsh R.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016.
2004 Feb 27 [updated 2013 Sep 19].

12.

Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry.

Purtilo DT, Sakamoto K, Barnabei V, Seeley J, Bechtold T, Rogers G, Yetz J, Harada S.

Am J Med. 1982 Jul;73(1):49-56.

PMID:
6283885
13.

XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease.

Marsh RA, Madden L, Kitchen BJ, Mody R, McClimon B, Jordan MB, Bleesing JJ, Zhang K, Filipovich AH.

Blood. 2010 Aug 19;116(7):1079-82. doi: 10.1182/blood-2010-01-256099. Epub 2010 May 20.

14.

Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease.

Grierson HL, Skare J, Hawk J, Pauza M, Purtilo DT.

Am J Med Genet. 1991 Sep 1;40(3):294-7.

PMID:
1683154
15.

Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome.

Sun J, Ying W, Liu D, Hui X, Yu Y, Wang J, Wang X.

Scand J Immunol. 2013 Nov;78(5):463-7. doi: 10.1111/sji.12103.

16.

SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis.

Yang X, Miyawaki T, Kanegane H.

Pediatr Int. 2012 Aug;54(4):447-54. doi: 10.1111/j.1442-200X.2012.03683.x. Review.

PMID:
22672194
17.
18.

Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.

Sumegi J, Huang D, Lanyi A, Davis JD, Seemayer TA, Maeda A, Klein G, Seri M, Wakiguchi H, Purtilo DT, Gross TG.

Blood. 2000 Nov 1;96(9):3118-25.

19.

Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis and X-linked lymphoproliferative disease: a mimicker of sepsis in the pediatric intensive care unit.

Mischler M, Fleming GM, Shanley TP, Madden L, Levine J, Castle V, Filipovich AH, Cornell TT.

Pediatrics. 2007 May;119(5):e1212-8. Epub 2007 Apr 2.

PMID:
17403820
20.

Epstein-Barr virus induced hemophagocytic lymphohistiocytosis in X-linked lymphoproliferative disease.

Sankararaman S, Riel-Romero RM, Jeroudi M, Gonzalez-Toledo E.

J Neurosci Rural Pract. 2014 Apr;5(2):171-4. doi: 10.4103/0976-3147.131669.

Items per page

Supplemental Content

Write to the Help Desk